Literature DB >> 11411825

Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study.

M F Grunebaum1, P J Weiden, M Olfson.   

Abstract

BACKGROUND: Little is known about risk factors for and predictors of medication nonadherence within residential facilities. This pilot study examined the association between medication adherence and level of supervision and other environmental and clinical variables among patients with schizophrenia and related psychotic disorders living in supported housing.
METHOD: A convenience sample of 74 adult residents with schizophrenia and related psychotic disorders (DSM-IV criteria) living in 4 supported housing facilities in New York City were assessed by their treating psychiatrist for medication cessation during the previous month. Demographic characteristics, medications, supervision, global function as measured by the Global Assessment of Functioning (GAF), and substance abuse were also assessed. A priori hypotheses were that regimen complexity would be directly and medication supervision would be inversely related to medication nonadherence.
RESULTS: In multivariate models, lack of direct medication supervision, negative medication attitude, and lower GAF score were associated with increased medication nonadherence in the recent past.
CONCLUSION: This pilot study suggests that direct supervision of medication is associated with better adherence in residential treatment settings. This finding is relevant for mental health service planners and clinicians working in these settings.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11411825     DOI: 10.4088/jcp.v62n0515

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  12 in total

Review 1.  Association between medication regimen complexity and pharmacotherapy adherence: a systematic review.

Authors:  Laís Lessa Pantuzza; Maria das Graças Braga Ceccato; Micheline Rosa Silveira; Luane Mendes Ribeiro Junqueira; Adriano Max Moreira Reis
Journal:  Eur J Clin Pharmacol       Date:  2017-08-04       Impact factor: 2.953

2.  Measuring strategies used by mental health providers to encourage medication adherence.

Authors:  Beth Angell
Journal:  J Behav Health Serv Res       Date:  2006-01       Impact factor: 1.505

Review 3.  Tactics and technologies to manage nonadherence in patients with schizophrenia.

Authors:  William M Glazer; Mathew J Byerly
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

4.  Characteristics of homeless adults with serious mental illness served by a state mental health transitional shelter.

Authors:  Mark Viron; Iruma Bello; Oliver Freudenreich; Derri Shtasel
Journal:  Community Ment Health J       Date:  2013-05-24

5.  Treatment compliance in patients with comorbid psychiatric and substance use disorders.

Authors:  Diane M Herbeck; Diana J Fitek; Dace S Svikis; Ivan D Montoya; Steven C Marcus; Joyce C West
Journal:  Am J Addict       Date:  2005 May-Jun

6.  Antipsychotic Adherence Intervention for Veterans over 40 with Schizophrenia: Results of a Pilot Study.

Authors:  Dinesh Mittal; Richard R Owen; Jonathan P Lacro; Pharm D; Reid D Landes; Mark Edlund; Marcia Valenstein; Dilip V Jeste
Journal:  Clin Schizophr Relat Psychoses       Date:  2009-01-01

Review 7.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

8.  Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.

Authors:  Birgit Janssen; Wolfgang Gaebel; Martin Haerter; F Komaharadi; Birgit Lindel; Stefan Weinmann
Journal:  Psychopharmacology (Berl)       Date:  2006-05-19       Impact factor: 4.530

9.  Poor response to treatment: beyond medication.

Authors:  César Carvajal
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

10.  Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection.

Authors:  Leslie Citrome
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.